Third‐generation continuous‐flow left ventricular assist devices: a comparative outcome analysis by device type

Third‐generation continuous‐flow left ventricular assist devices: a comparative outcome analysis by device type

Abstract Aims Continuous‐flow left ventricular assist devices (CF‐LVADs) have become a standard of care in end‐stage heart failure. Limited data exist comparing outcomes of HeartMate3 (HM3) and HeartWare HVAD (HW). We aimed to compare midterm outcomes of these devices. Methods and results Investigat...

Full description

Bibliographic Details
Main Authors:	Maks Mihalj, Paul Philipp Heinisch, Patrick Schober, Monika Wieser, Michele Martinelli, Theo M.M.H. deBy, Joerg C. Schefold, Markus M. Luedi, Alexander Kadner, Thierry Carrel, Paul Mohacsi, Lukas Hunziker, David Reineke
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Series:	ESC Heart Failure
Subjects:	Left ventricular assist device LVAD HeartMate3 HeartWare HVAD Outcome comparison
Online Access:	https://doi.org/10.1002/ehf2.13794

Similar Items

HeartWare HVAD: Postoperative issues in our first patient
by: Sarvesh Pal Singh, et al.
Published: (2017-01-01)

Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom
by: Priyansh Faldu, et al.
Published: (2022-07-01)

Endovascular stenting of an HVAD™ outflow graft pseudoaneurysm that exerts compression and kinking stenosis on the soft portion of the prosthesis
by: Mohamed Elbayomi, et al.
Published: (2023-05-01)

Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices
by: Maximilian Tscharre, et al.
Published: (2022-02-01)

Use of Intracorporeal Durable LVAD Support in Children Using HVAD or HeartMate 3—A EUROMACS Analysis
by: Martin Schweiger, et al.
Published: (2023-08-01)

Pericardial release for early LVAD malalignment a less invasive approach
by: Eric I. Jeng, et al.
Published: (2021-03-01)

Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
by: Alessandra Francica, et al.
Published: (2023-09-01)

Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry
by: Alessandra Francica, et al.
Published: (2023-10-01)

What happens when a disruptive technology gets disrupted?
by: Lauren E. Meece, et al.
Published: (2021-06-01)

Chest radiographs of cardiac devices (Part 2): Ventricular assist devices
by: Rishi P. Mathew, et al.
Published: (2019-07-01)

Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States
by: Teruhiko Imamura, et al.
Published: (2020-03-01)

Totally percutaneous endovascular repair of HeartMate 3 ventricular assistive device outflow graft pseudoaneurysm
by: Mark D. Balceniuk, MD, MPH, et al.
Published: (2020-12-01)

Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes
by: Sachin P. Shah, et al.
Published: (2016-04-01)

Management issues during HeartWare left ventricular assist device implantation and the role of transesophageal echocardiography
by: Sanjay Orathi Patangi, et al.
Published: (2013-01-01)

Monitoring pulmonary pressures during long‐term continuous‐flow left ventricular assist device and fixed pulmonary hypertension: redefining alleged pathophysiological mechanisms?
by: Chantal C. De Bakker, et al.
Published: (2020-04-01)

Left Ventricular Assist Device Implantation in a Patient with Ventricular Pseudoaneurysm
by: Dejan Radakovic, et al.
Published: (2022-01-01)

Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation
by: Mohamed Laimoud, et al.
Published: (2023-12-01)

Implantable devices: a bridge to heart transplantation
by: D. Zimpfer, et al.
Published: (2019-01-01)

The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation
by: Alexandros Briasoulis, et al.
Published: (2020-06-01)

Sex-based considerations for implementation of ventricular assist device therapy
by: K. Candis Jones-Ungerleider, et al.
Published: (2022-10-01)

Total Joint Arthroplasty in Patients With an Implanted Left Ventricular Assist Device
by: John H. Rosenberg, MD, et al.
Published: (2023-02-01)

Eight months of HeartMate II device support without drug therapy
by: Kewal Krishan, et al.
Published: (2017-01-01)

Left Ventricular Assist Device Implantation in a Thrombosed Apical Aneurysm
by: Daniele Masarone, et al.
Published: (2021-07-01)

Combined mechanical circulatory support for ventricular fibrillation in left ventricular assist device patient
by: Mahmood Abu Akel, et al.
Published: (2022-10-01)

Biventricular assist devices and total artificial heart: Strategies and outcomes
by: Taiyo Kuroda, et al.
Published: (2023-01-01)

Adverse events with HeartMate-3 Left ventricular assist device: Results from the Manufacturer and User Facility Device Experience (MAUDE) database
by: Joseph N. Heaton, et al.
Published: (2021-11-01)

Successful conservative management of left ventricular assist device candidates
by: Ofer Havakuk, et al.
Published: (2023-02-01)

Left Ventricular Assist Device Pump Obstruction Reduces Native Heart Efficiency
by: Ricardo Montes, et al.
Published: (2023-12-01)

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
by: Cecilia Berardi, et al.
Published: (2022-04-01)

Right and left ventricular assist devices are an option for bridge to heart transplantCentral MessagePerspective
by: Yaron D. Barac, MD, PhD, et al.
Published: (2022-03-01)

Racial disparities and outcomes of left ventricular assist device implantation as a bridge to heart transplantation
by: Alexis Kofi Okoh, et al.
Published: (2020-10-01)

Ischemic cardiomyopathy is an independent predictor of mortality in patients presenting for Heart Mate II left ventricular assist device implantation
by: Sanjay Kumar, et al.
Published: (2017-01-01)

Review of devices and clinical need for non-blood contacting mechanical circulatory support
by: Shannon N. Ingram, et al.
Published: (2022-12-01)

Severe Pulmonary Bleeding after Assist Device Implantation: Incidence, Risk Factors and Prognostic Impact
by: Bernd Panholzer, et al.
Published: (2022-03-01)

Left Ventricular Assist Device Implantation in Cancer-Therapy-Related Heart Failure
by: Johanna Mulzer, et al.
Published: (2022-09-01)

Preoperative hemodynamics as predictors of right heart failure post-left ventricular assist device
by: Erik J. Orozco-Hernandez, et al.
Published: (2022-08-01)

Temporary left ventricular assist device for complete recovery from reversible acute heart failure due to tumor necrosis factor-α inhibitor
by: Marie-Camille Soucy-Giguere, et al.
Published: (2019-06-01)

MediGuide-assisted atrial flutter ablation in a patient with a HeartMate II left ventricular assist device
by: Hien Kiem Nguyen Thanh, MD, et al.
Published: (2015-09-01)

Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device
by: Kinam Shin, et al.
Published: (2024-03-01)

A Multiphysics Biventricular Cardiac Model: Simulations With a Left-Ventricular Assist Device
by: Azam Ahmad Bakir, et al.
Published: (2018-09-01)